MERGE LABS
LIVE

Serial Number

99500413

Owner

Labs for Humanity, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Nov 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MERGE LABS Trademark

Serial Number: 99500413

MERGE LABS is a trademark filed by Labs for Humanity, Inc. on November 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Labs for Humanity, Inc. (2 trademarks)

1209 Orange St
Wilmington, DE 19801

Entity Type: 58

Trademark Details

Filing Date

November 17, 2025

Registration Date

Not Registered

Published for Opposition

October 20, 2026

Goods & Services

Downloadable and recorded software for providing direct interfaces between the brain and computer systems; downloadable and recorded software for directly controlling and communicating with computers and electronic devices via neural activity; downloadable and recorded software for controlling brain-computer interface (BCI) devices; downloadable and recorded software for interpreting and decoding neural activity; downloadable and recorded software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; Brain-computer interface (BCI) devices that allow users to interface with computer hardware via brain activity; interfaces for computers in the nature of implants for directly controlling and communicating with computers and electronic devices via neural activity

Providing online non-downloadable software featuring software that provides a direct interface between the brain and computer systems; software as a service (SAAS) services featuring software that allows users to directly control and communicate with computers using neural activity; providing online non-downloadable software for controlling brain-computer interface (BCI) devices; providing online non-downloadable software and recorded software for interpreting and decoding neural activity; providing online non-downloadable software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; research and development in the field of brain-computer interfaces (BCI), direct communication between brain activity and computers, neurostimulation, and therapeutics; providing information in the field of brain-computer interfaces (BCI); gene therapy research; research and development in the field of artificial intelligence (AI) and machine learning (ML) for use in brain-computer interface (BCI) devices, neurostimulation, and therapeutics

gene therapy products, namely, pharmaceutical preparations for enabling the use of brain computer interface (BCI) systems

Brain-computer interface (BCI) devices being ultrasound transceiver implants for medical use; implants for directly controlling and communicating with computers and electronic devices via neural activity for medical purposes; medical devices for opening the blood-brain barrier; electronic devices, namely, computer displays, monitors, and controllers therefor used for directly modulating brain states for the purpose of diagnosis of conditions and detecting brain activity in an individual; medical devices for detecting brain function

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 2, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 2, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2025 NWOS
NEW APPLICATION ENTERED
Nov 17, 2025 NWAP